Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Guanabenz

EU orphan designation number: EU/3/09/625   
Active ingredient: Guanabenz
Indication: Treatment of traumatic spinal cord injury
Sponsor: Acure Pharma AB
Ulleråkersvägen 38, 75643 Uppsala, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/05/2009 Orphan designation EMEA/OD/116/08 (2009)3457 of 29/04/2009